We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

152 hedge funds and large institutions have $1.26B invested in Acorda Therapeutics in 2017 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 40 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 40

26% more capital invested

Capital invested by funds: $1B → $1.26B (+$258M)

6% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 17

1% more funds holding

Funds holding: 151 → 152 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

19% less call options, than puts

Call options by funds: $6.72M | Put options by funds: $8.28M

Holders
152
Holders Change
+1
Holders Change %
+0.66%
% of All Funds
3.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
61
Reduced
40
Closed
17
Calls
$6.72M
Puts
$8.28M
Net Calls
-$1.56M
Net Calls Change
+$10.6M

Top Buyers

1
PHS
PFM Health Sciences
California
+$32.1M
2
SCM
Scopia Capital Management
New York
+$27.5M
3
Invesco
Invesco
Georgia
+$15.4M
4
BBA
Baker Bros. Advisors
New York
+$11.4M
5
Deutsche Bank
Deutsche Bank
Germany
+$9.45M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$20.3M
2
CI
Cambiar Investors
Colorado
-$11.8M
3
GTC
Ghost Tree Capital
New York
-$7.88M
4
State Street
State Street
Massachusetts
-$6.39M
5
USAA
United Services Automobile Association
Texas
-$4.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCP
101
GSA Capital Partners
United Kingdom
$541K +$503K +191 New
DekaBank Deutsche Girozentrale
102
DekaBank Deutsche Girozentrale
Germany
$504K – – –
UBS AM
103
UBS AM
Illinois
$498K +$464K +176 New
LSERS
104
Louisiana State Employees Retirement System
Louisiana
$447K – – –
MERSOM
105
Municipal Employees' Retirement System of Michigan
Michigan
$414K +$145K +55 +60%
O
106
OppenheimerFunds
New York
$394K -$148K -56 -29%
HCMT
107
Highland Capital Management (Texas)
Texas
$367K +$340K +129 New
BCM
108
BlueCrest Capital Management
Jersey
$345K +$319K +121 New
Simplex Trading
109
Simplex Trading
Illinois
$325K -$23.7K -9 -7%
AG
110
Aperio Group
California
$325K +$18.4K +7 +6%
JFG
111
Jefferies Financial Group
New York
$317K +$295K +112 New
GIA
112
Gargoyle Investment Advisor
New Jersey
$311K – – –
Citadel Advisors
113
Citadel Advisors
Florida
$310K -$20.3M -7,713 -99%
N
114
Natixis
France
$303K +$282K +107 New
Bank of Montreal
115
Bank of Montreal
Ontario, Canada
$280K -$1.1M -416 -81%
MSA
116
Mason Street Advisors
Wisconsin
$279K +$5.27K +2 +2%
TRSOTSOK
117
Teachers Retirement System of the State of Kentucky
Kentucky
$277K – – –
Public Employees Retirement Association of Colorado
118
Public Employees Retirement Association of Colorado
Colorado
$260K – – –
CG
119
Cutler Group
California
$257K +$132K +50 +122%
PIA
120
Piedmont Investment Advisors
North Carolina
$240K +$2.63K +1 +1%
CGH
121
Crossmark Global Holdings
Texas
$233K +$216K +82 New
TSS
122
Two Sigma Securities
New York
$220K +$203K +77 New
SOADOR
123
State of Alaska Department of Revenue
Alaska
$218K – – –
GHCM
124
Glen Harbor Capital Management
California
$161K +$26.3K +10 +21%
MCIM
125
Meadow Creek Investment Management
Georgia
$132K +$21.1K +8 +21%
3 4
5
6 7

ACOR Hedge Fund Activity: Q3 2017 in Review

152 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q3 2017, worth a combined $1.26B — up 26% from $1B a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new ACOR positions and 17 closed out — a net gain of 1 holder — while 61 added to existing stakes and 40 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $32.1M. The largest seller was Citadel Advisors, cutting an estimated $20.3M.

  • 152 institutional investors held Acorda Therapeutics (ACOR) as of Q3 2017, up from 151 in Q2 2017.
  • Funds reported $1.26B of Acorda Therapeutics stock for Q3 2017, up 26% quarter-over-quarter.
  • 18 funds opened new Acorda Therapeutics positions in Q3 2017 and 17 closed out, a net change of +1 holder.
  • The largest Acorda Therapeutics buyer in Q3 2017 was PFM Health Sciences, an estimated $32.1M added.
  • The largest Acorda Therapeutics seller in Q3 2017 was Citadel Advisors, an estimated $20.3M sold.

Based on aggregated 13F filings for Q3 2017.